Niall Redmond

Intent: To progress Programme for Government commitments linked to orphan medicines access and rare disease policy.

Details: Rare Disease Policy in Ireland

Intent: Securing support for three legislative provisions: (1) reforming procurement to mandate Best Price-Quality Ratio (BPQR) over lowest unit price; (2) building health resilience through open, zero-tariff supply chains without rigid localization; and (3) creating a workable PFAS transition pathway with targeted, time-limited diagnostic derogations to safeguard patient access and diagnostic supply.

Details: Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union.

Intent: To contribute to discussions, in the context of Ireland’s EU Presidency, on the EU Biotech Act and related health-policy initiatives and their potential contribution to life-sciences innovation, research, clinical trials and healthcare outcomes in Ireland and Europe.

Details: Engagements on life-sciences policy, innovation and competitiveness in Ireland and Europe

Intent: Securing support to prioritize targeted improvements in the EU Biotech Act: (1) converting Article 27 Supplementary Protection Certificate (SPC) extension criteria from cumulative to non-cumulative; (2) streamlining multi-country clinical trial approvals by establishing a single orchestrating review body; and (3) protecting resilient global supply chains by recognizing trusted non-EU trading partners without introducing protectionist quotas.

Details: Progression and refinement of legislative proposals within the EU Biotech Act during Ireland’s H2 2026 Presidency of the Council of the European Union.

Intent: Embedding metric-driven performance indicators to ensure focus on clinical trial density and speed of access to new medicines, and establishing a permanent public-private National Life Science Council to support the development and delivery of the strategy

Details: Quantitative target-setting and governance structures for Ireland’s National Life Science Strategy.

Intent: Share correspondence on behalf of Medicines for Ireland with Niall Redmond, Assistant Secretary at the Department of Health, regarding MFI’s EU Presidency event.

Details: Correspondence to Mr. Niall Redmond in relation to MFI'S EU Presidency Event

Intent: Enhanced priority to be given to competitiveness and contribution to the European economy of the pharmaceutical sector particularly via the proposed EU BioTech Act and the Critical Medicines Act; (ii) Implementation of reforms in Draghi Report; (iii) Treatment of spending on medicines as an investment in economy and society rather than a cost.

Details: EU Presidency Associated event with Commission VarHelyi on European Competitiveness and the role of Life Sciences and the Pharmaceutical Industry.

Intent: The commencement of the statutory process to review of pharmacy fees under the public services pay and pensions act

Details: PSPPA Pharmacy Fee Review

Intent: Ensure sustained growth of Ireland's Life Sciences ecosystem via National Strategy.

Details: Inter-Ministerial Meeting convened in Royal College of Physicians

Intent: Changes in policy to improve the early identification and management of chronic kidney disease.

Details: Pre-budget submission advocating for i)Kidney Disease Registry; ii)Screening for CKD (early detection; iii)Primary Care Clinical Lead to drive CKD management; iv)commitment to a living donor transplantation target